Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LGMK .14 expanded AI and Machine learning on pattern recognition and detection fall- from last years shareholder letter
How much is the 5 Year VA contact worth ?
12M cash assuming $2M cash burn for 1st quarter -begins selling new product
LGMK in here .185 Nxt-ID my favorite trading stock 9 out of 10 wins here
PHUN .74 similar to GFAI
FRGT $3.31
FRGT $3.15
FRGT $2.69 all walls getting knocked down
FRGT $2.63
FRGT $2.50 nice pop
HKD $9 Pre Market
This was a $1 around August its not even a year yet why are they delisting this is BS
HKD $8.38
HKD broke $8
ENSV .51 its safe now
ENSV .59
ENSV re entered .55
ENSV .59 trying some
FLGC .33 AH -Monday Webcast looking good
FLGC .275 trying some
APTX .14 trying some
What do you think happens
TCON $2.06 supposedly a big settlement coming
NIR $3 debacle = whats the market cap here
MARK news out no premarket trading
CDTX might test .90
BRDS .155
SLNH .365 news out Green bit coin play
SLNH .33 April start up in Texas
SLNH in at .30
TTOO .60
TTOO .56 volume
Co has the patent and need a buyout now they can't go it alone they would have to do another 3 or 4 offerings and another couple of R/S
TENX 70 on patent news
We might end up getting CVR's --Contigent Value Rights so after a buyout shareholders still get certain benefits from the Levosimendan and Imatinib approvals
Lets see what Roth Capital partners comes up with its been six months they must have suitor by now
After the patent is issued TENX worth $100MM
TENX .58
The likely Buy out will be from Novartis they worked on the failed trials of Imatinib due to gastrointestinal problems
UFAB .24 in some